The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Enhanced drug delivery with nanocarriers: a comprehensive review of recent advances in breast cancer detection and treatment
Open accessAbstract
Breast cancer (BC) remains a leading cause of morbidity and mortality among women worldwide, with triple-negative breast cancer (TNBC) posing significant treatment challenges due to its aggressive phenotype and resistance to conventional therapies. Recent advancements in nanocarrier technology offer promising solutions for enhancing drug delivery, improving bioavailability, and increasing drug accumulation at tumor sites through targeted approaches. This review delves into the latest innovations in BC detection and treatment, highlighting the role of nanocarriers like polymeric micelles, liposomes, and magnetic nanoparticles in overcoming the limitations of traditional therapies. Additionally, the manuscript discusses the integration of cutting-edge diagnostic tools, such as multiplex PCR-Nested Next-Generation Sequencing (mPCR-NGS) and blood-based biomarkers, which are revolutionizing early detection and molecular profiling of BC. The convergence of these technologies not only enhances therapeutic outcomes but also paves the way for personalized medicine in BC management. This comprehensive review underscores the potential of nanocarriers in transforming BC treatment and emphasizes the critical importance of early detection in improving patient prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early studies predominantly focused on high-atomic-number (high-Z) materials, including gold, silver, gadolinium, and hafnium-based nanoparticles, with the primary objective of maximizing radiation energy deposition and secondary electron generation [9,85,95,96].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These systems established the proof-of-concept that nanomaterials could enhance radiation-induced damage, but they also highlighted important limitations related to tumor hypoxia, antioxidant defenses, heterogeneous intratumoral distribution, and variable nanoparticle accumulation [11,12,25,95,97].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [95]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breast Cancer Treatment: A Review
Waks, A. G., & Winer, E. P. (2019) · JAMA · doi:10.1001/jama.2018.19323 · Cited by 4,804
Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors
Hardman, R. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8284 · Cited by 2,303 · cited 1×
“However, ligand conjugation may still lead to off-target effects, as seen with transferrin or folic acid-coated nanoparticles, which can affect non-target organs like the pancreas, liver, and brain [115, 116].”
BackgroundDendrimers in biomedical applications—reflections on the field
SVENSON, S., & TOMALIA, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.018 · Cited by 1,919
Garrido-Castro, A. C., Lin, N. U., & Polyak, K. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1177 · Cited by 1,451 · cited 1×
“Chemotherapy continues to be the gold standard of treatment since medicines that target particular molecular targets have only sometimes improved the outcomes of people with TNBC clinically meaningfully [30].”
BackgroundAwareness and current knowledge of breast cancer
Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017) · Biological Research · doi:10.1186/s40659-017-0140-9 · Cited by 1,406
Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer
Murthy, R. K., Loi, S., Okines, A., Paplomata, E., Hamilton, E., Hurvitz, S. A., Lin, N. U., Borges, V., Abramson, V., Anders, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1914609 · Cited by 1,326 · cited 1×
“Approved by the FDA, tucatinib, when combined with trastuzumab and capecitabine, improved progression-free survival (PFS) and overall survival (OS) in advanced HER2 + metastatic BC, as shown in the phase II HER2CLIMB trial [112].”
Background"Cascade"- and "Nonskid-Chain-like" Syntheses of Molecular Cavity Topologies
BUHLEIER, E., WEHNER, W., & VÖGTLE, F. (1978) · Synthesis · doi:10.1055/s-1978-24702 · Cited by 1,285
Promises, facts and challenges for carbon nanotubes in imaging and therapeutics
Kostarelos, K., Bianco, A., & Prato, M. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.241 · Cited by 787
Various types and management of breast cancer: An overview
Sharma, G., Dave, R., Sanadya, J., Sharma, P., & Sharma, K. K. (2010) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/2231-4040.72251 · Cited by 719
Research works printed but not linked: 2
- Liu Z, Liu Y, Liu Z. Recent advances in the growth mechanisms of single-walled carbon nanotubes and multi-walled carbon nanotubes. Front Nanotechnol. 2021;3:648297.
- Kesharwani P, Iyer AK, Ljubimova JY. Dendrimer-based nanocarriers for drug delivery. Small. 2015;11(42):5086–106.
Cited by
The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer
Kannan, K., Srinivasan, A., Kannan, A., & Ali, N. (2025) · Cancers · doi:10.3390/cancers17172938 · Cited by 47
“While Xiong et al. (2025) [14] and Dhiman et al. (2024) [15] offered broad overviews of BC pathophysiology and nanocarrier applications, this review delivers a more granular analysis of various resistance mechanisms reported in the literature.”
Izadiyan, Z., Webster, T. J., Kia, P., Kalantari, K., Misran, M., Rasouli, E., Esfahan, Z. M., & Shameli, K. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s488545 · Cited by 47
Samad, M. A., Ahmad, I., Zughaibi, T. A., Suhail, M., Zaidi, S. K., Al-Abbasi, F. A., & Tabrez, S. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100268 · Cited by 35
Recent strategies in diagnosis, screening, prevention, and treatment of breast cancer in young women
Sharma, D. K., & Saripilli, R. (2025) · Discover Oncology · doi:10.1007/s12672-025-03180-0 · Cited by 27
Ramayanam, N. R., Bukke, S. P. N., Moka, M. K., Dehingia, H., Bordoloi, A., Debbarma, R., Kudumula, P. R., Vuyyala, B., Prasad, P. D., & Catherine, A. (2025) · Discover Nano · doi:10.1186/s11671-025-04308-5 · Cited by 25
“Cell membrane-covered nanoparticles, which make use of the precise attributes of diverse cellular types, offer greater biocompatibility and focused transport, growing treatment specificity for TNBC [41].”
Metadata
- Authors
- Dhiman, R., Bazad, N., Mukherjee, R., Himanshu, Gunjan, Leal, E., Ahmad, S., Kaur, K., Raj, V. S., Chang, C.-M., & Pandey, R. P.
- Affiliations
- SRM University (IN)
- Chang Gung University (TW)
- Universidade Federal do Pará (BR)
- University of Ha'il (SA)
- Chandigarh University (IN)
- University of Petroleum and Energy Studies (IN)
- Corresponding author
- Chang, Chung-Ming
- Pandey, Ramendra Pati
- ORCID
- Venue
- Discover Nano
- Published
- 2024-09-07
- Volume
- 19
- Issue
- 1
- Pages
- 143-143
- ISSN
- 2731-9229 (ISSN-L)
- PMC
- PMC11380656
- OpenAlex
- W4402331566
- Cited by
- 40
- References
- 119
- Citations by year
- 2026: 21 · 2025: 18 · 2024: 1
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Discover Nano (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Pharmacology and Nanomedicine Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, triple-negative breast cancer, nanocarriers, drug delivery, polymeric micelles, liposomes, magnetic nanoparticles, targeted drug delivery, tumor accumulation, early cancer detection, blood-based biomarkers, molecular profiling, personalized medicine, treatment resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhanced drug delivery with nanocarriers: a comprehensive review of recent advances in breast cancer detection and treatment. https://app.cochat.ai/papers/10.1186/s11671-024-04086-6
- The paper
- Dhiman, R., Bazad, N., Mukherjee, R., Himanshu, Gunjan, Leal, E., Ahmad, S., Kaur, K., Raj, V. S., Chang, C.-M., & Pandey, R. P. (2024). Enhanced drug delivery with nanocarriers: a comprehensive review of recent advances in breast cancer detection and treatment. Discover Nano. https://doi.org/10.1186/s11671-024-04086-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


